Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma

Lawrence Einhorn, B. E. Furnas, W. H. Bond, R. J. Rohn

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Thirty four patients (median age 59; range 24 to 77) with far advanced gastrointestinal neoplasms (colorectal 24, pancreas 6, stomach 2, and hepatoma 2) were treated with combined 5 FU 800 mg/M2 as a continuous 24 hr IV infusion in 1,000 cc D5W for 5 consecutive days and Methyl CCNU 150 mg/M2 p.o. on the first day of the 5 FU infusion. Three courses were given at 4 wk intervals; then maintenance chemotherapy consisted of oral weekly 5 FU (500 to 1000 mg) and Methyl CCNU, 125 mg/M2 p.o. every 4 wk. Partial remissions were observed in 7 of 25 colorectal cancers (median duration 6 mth; range 3 to 9+ mth), 1 of 6 pancreatic (duration 4 mth), 1 of 2 hepatomas (duration 4 mth), and 0 of 2 stomach cancers. There were 6 of 13 responses in female patients, and only 3 of 21 responses in male patients. Toxicity was minimal and consisted of mild nausea and vomiting and myelosuppression. Myelosuppression was minimal during the first 3 mth of therapy, with the median lowest granulocyte count 2,500 and only 6 patients and platelet counts below 100,000. There was only one episode of granulocytopenia related sepsis and no episodes of thrombocytopenia related bleeding.

Original languageEnglish
Title of host publicationProceedings of the American Association for Cancer Research
Volume16
Edition66
StatePublished - 1975

Fingerprint

Semustine
Combination Drug Therapy
Fluorouracil
Adenocarcinoma
Hepatocellular Carcinoma
Maintenance Chemotherapy
Agranulocytosis
Gastrointestinal Neoplasms
Platelet Count
Granulocytes
Thrombocytopenia
Nausea
Stomach Neoplasms
Vomiting
Pancreas
Colorectal Neoplasms
Sepsis
Stomach
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Einhorn, L., Furnas, B. E., Bond, W. H., & Rohn, R. J. (1975). Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma. In Proceedings of the American Association for Cancer Research (66 ed., Vol. 16)

Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma. / Einhorn, Lawrence; Furnas, B. E.; Bond, W. H.; Rohn, R. J.

Proceedings of the American Association for Cancer Research. Vol. 16 66. ed. 1975.

Research output: Chapter in Book/Report/Conference proceedingChapter

Einhorn, L, Furnas, BE, Bond, WH & Rohn, RJ 1975, Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma. in Proceedings of the American Association for Cancer Research. 66 edn, vol. 16.
Einhorn L, Furnas BE, Bond WH, Rohn RJ. Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma. In Proceedings of the American Association for Cancer Research. 66 ed. Vol. 16. 1975
Einhorn, Lawrence ; Furnas, B. E. ; Bond, W. H. ; Rohn, R. J. / Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma. Proceedings of the American Association for Cancer Research. Vol. 16 66. ed. 1975.
@inbook{e49624166dcc4ac69138b1da9c694a89,
title = "Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma",
abstract = "Thirty four patients (median age 59; range 24 to 77) with far advanced gastrointestinal neoplasms (colorectal 24, pancreas 6, stomach 2, and hepatoma 2) were treated with combined 5 FU 800 mg/M2 as a continuous 24 hr IV infusion in 1,000 cc D5W for 5 consecutive days and Methyl CCNU 150 mg/M2 p.o. on the first day of the 5 FU infusion. Three courses were given at 4 wk intervals; then maintenance chemotherapy consisted of oral weekly 5 FU (500 to 1000 mg) and Methyl CCNU, 125 mg/M2 p.o. every 4 wk. Partial remissions were observed in 7 of 25 colorectal cancers (median duration 6 mth; range 3 to 9+ mth), 1 of 6 pancreatic (duration 4 mth), 1 of 2 hepatomas (duration 4 mth), and 0 of 2 stomach cancers. There were 6 of 13 responses in female patients, and only 3 of 21 responses in male patients. Toxicity was minimal and consisted of mild nausea and vomiting and myelosuppression. Myelosuppression was minimal during the first 3 mth of therapy, with the median lowest granulocyte count 2,500 and only 6 patients and platelet counts below 100,000. There was only one episode of granulocytopenia related sepsis and no episodes of thrombocytopenia related bleeding.",
author = "Lawrence Einhorn and Furnas, {B. E.} and Bond, {W. H.} and Rohn, {R. J.}",
year = "1975",
language = "English",
volume = "16",
booktitle = "Proceedings of the American Association for Cancer Research",
edition = "66",

}

TY - CHAP

T1 - Combination chemotherapy with 5 day continuous infusion 5 fluorouracil (5 FU) and methyl CCNU in disseminated enteric adenocarcinoma

AU - Einhorn, Lawrence

AU - Furnas, B. E.

AU - Bond, W. H.

AU - Rohn, R. J.

PY - 1975

Y1 - 1975

N2 - Thirty four patients (median age 59; range 24 to 77) with far advanced gastrointestinal neoplasms (colorectal 24, pancreas 6, stomach 2, and hepatoma 2) were treated with combined 5 FU 800 mg/M2 as a continuous 24 hr IV infusion in 1,000 cc D5W for 5 consecutive days and Methyl CCNU 150 mg/M2 p.o. on the first day of the 5 FU infusion. Three courses were given at 4 wk intervals; then maintenance chemotherapy consisted of oral weekly 5 FU (500 to 1000 mg) and Methyl CCNU, 125 mg/M2 p.o. every 4 wk. Partial remissions were observed in 7 of 25 colorectal cancers (median duration 6 mth; range 3 to 9+ mth), 1 of 6 pancreatic (duration 4 mth), 1 of 2 hepatomas (duration 4 mth), and 0 of 2 stomach cancers. There were 6 of 13 responses in female patients, and only 3 of 21 responses in male patients. Toxicity was minimal and consisted of mild nausea and vomiting and myelosuppression. Myelosuppression was minimal during the first 3 mth of therapy, with the median lowest granulocyte count 2,500 and only 6 patients and platelet counts below 100,000. There was only one episode of granulocytopenia related sepsis and no episodes of thrombocytopenia related bleeding.

AB - Thirty four patients (median age 59; range 24 to 77) with far advanced gastrointestinal neoplasms (colorectal 24, pancreas 6, stomach 2, and hepatoma 2) were treated with combined 5 FU 800 mg/M2 as a continuous 24 hr IV infusion in 1,000 cc D5W for 5 consecutive days and Methyl CCNU 150 mg/M2 p.o. on the first day of the 5 FU infusion. Three courses were given at 4 wk intervals; then maintenance chemotherapy consisted of oral weekly 5 FU (500 to 1000 mg) and Methyl CCNU, 125 mg/M2 p.o. every 4 wk. Partial remissions were observed in 7 of 25 colorectal cancers (median duration 6 mth; range 3 to 9+ mth), 1 of 6 pancreatic (duration 4 mth), 1 of 2 hepatomas (duration 4 mth), and 0 of 2 stomach cancers. There were 6 of 13 responses in female patients, and only 3 of 21 responses in male patients. Toxicity was minimal and consisted of mild nausea and vomiting and myelosuppression. Myelosuppression was minimal during the first 3 mth of therapy, with the median lowest granulocyte count 2,500 and only 6 patients and platelet counts below 100,000. There was only one episode of granulocytopenia related sepsis and no episodes of thrombocytopenia related bleeding.

UR - http://www.scopus.com/inward/record.url?scp=17544387248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17544387248&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:17544387248

VL - 16

BT - Proceedings of the American Association for Cancer Research

ER -